[Clinical application of a new fibrin adhesive (Tisseel) in urologic surgery].
Our experience with the use of a new biological tissue adhesive (Tisseel) consisting of highly concentrated human fibrinogen, thrombin and factor XIII in urologic surgery is reported. In 21 operations (18 patients), Tisseel was used for the purpose of tissue adhesion and reduction of sutures of the renal parenchymal wound in nephrolithotomy, water tight sealing in suture part of expanded pyelolithtomy and vasovasostomy, and local hemostasis of oozing in prostatectomized fossa. Tisseel was not responsible for the two unsuccessful trials; and, undesirable complications due to this adhesive were few. Our results revealed that this new fibrin adhesive will be useful for urologic surgery.
Miyake
K
K
Gotoh
M
M
Sai
S
S
D000328:Adult; D000368:Aged; D000818:Animals; D007611:Aprotinin; D002122:Calcium Chloride; D004285:Dogs; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005260:Female; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen; D006801:Humans; D008297:Male; D008875:Middle Aged; D013917:Thrombin; D014014:Tissue Adhesives; D014566:Urogenital System / Q000601:surgery*; D014570:Urologic Diseases / Q000601:surgery
D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives; D005340:Fibrinogen; D007611:Aprotinin; D013917:Thrombin; D002122:Calcium Chloride